AI to Revolutionize Drug Discovery: Hassabis Predicts Months, Not Years, for Breakthroughs

DeepMind CEO Demis Hassabis believes AI could shorten drug discovery from years to months. Hassabis, who runs Google's AI unit and Isomorphic Labs, a division focused on drug discovery, expects significant progress in the next couple of years. He aims to cut the time needed to develop new medicines from years to months, and possibly even faster. Hassabis's company, Isomorphic Labs, has already formed partnerships with pharmaceutical companies like Eli Lilly and Novartis, and is working on treatments for cancer and immune disorders.